本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Xeris製藥

7.96
+0.17502.25%
成交量:134.40萬
成交額:1,059.93萬
市值:14.50億
市盈率:-77.99
高:7.99
開:7.78
低:7.73
收:7.78
52周最高:10.08
52周最低:5.25
股本:1.82億
流通股本:1.73億
量比:0.78
換手率:0.78%
股息:- -
股息率:- -
每股收益(TTM):-0.1020
每股收益(LYR):0.0032
淨資產收益率:-617.16%
總資產收益率:6.13%
市淨率:-149.00
市盈率(LYR):2,480.51

資料載入中...

2020/04/24

重要事件披露

Current report, items 1.01, 2.03, 5.03, and 9.01
2020/04/10

重要事件披露

Current report, items 5.02 and 9.01
2020/03/12

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2020/03/12

員工持股計劃

Securities to be offered to employees in employee benefit plans
2020/03/11

重要事件披露

Current report, items 2.02 and 9.01
2020/03/10

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/21

超過5%披露

Statement of acquisition of beneficial ownership by individuals
2020/02/14

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/14

超過5%披露

Statement of acquisition of beneficial ownership by individuals
2020/02/13

重要事件披露

Current report, items 1.01, 8.01, and 9.01
2020/02/13

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/11

重要事件披露

Current report, items 2.02 and 8.01
2020/02/07

超過5%披露

Statement of acquisition of beneficial ownership by individuals
2020/02/07

超過5%披露

Statement of acquisition of beneficial ownership by individuals
2020/01/10

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2019/11/08

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2019/11/07

季度報告

Quarterly report [Sections 13 or 15(d)]
2019/11/07

重要事件披露

Current report, items 2.02 and 9.01
2019/10/01

重要事件披露

Current report, items 5.02 and 9.01
2019/09/10

重要事件披露

Current report, items 1.01, 2.03, 8.01, and 9.01